← board
VREOF
distress 2/10 · well-funded / low risk$9.81+1%today-58% from 52w high
Revenue
$106M
Liquidity
$145M
Runway
—
Shares 1y
—
Price & events
-39.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.7%
1D
-1.8%
1W
-5.9%
1M
-34.2%
3M
-39.3%
6M
-27.3%
1Y
-27.7%
2Y
-80.8%
5Y
-78.1%
All
Overview
- Volume
- 14.70K
- 52 Week Range
- $9.56 – $23.10
- Float Shares
- 28.41M
- % Held by Insiders
- 33.16%
- % Held by Institutions
- 7.81%
- RVOL
- 1.06x
- Beta
- 0.07
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 5
- 2026-08-12earningsEarningsEarnings releaseyahoo
- 2025-12-16partnershipEntered into Asset Purchase Agreement to acquire PharmaCann's Colorado retail assets for $49M in stock.SEC 8-K
- 2025-10-10partnershipEntered restructuring support agreement with Schwazze and other parties.SEC 8-K
- 2025-10-10partnershipAcquired ~86% of Schwazze's senior secured notes for $62M in stock.SEC 8-K
- 2025-10-02partnershipEntered into definitive agreements to acquire 86% of Schwazze's senior secured convertible notesSEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- 2026-07-20Vireo's Five-State Agreement Expected to Add Up to 25 Dispensaries - Stock Titan
- 2026-07-19FLUENT Provides Update and Supplemental Disclosure on Circular to Approve All-Stock Transaction With Vireo Growth Inc. - 富途牛牛
- 2026-07-17FLUENT Provides Update and Supplemental Disclosure on Circular to Approve All-Stock Transaction With Vireo Growth Inc. - The Manila Times
- 2026-07-17FLUENT Provides Update and Supplemental Disclosure on Circular to Approve All-Stock Transaction With Vireo Growth Inc. - 富途牛牛
- 2026-07-02Vireo Growth Inc. Announces Pennsylvania Dispensary License Transaction, Expanding into its 11th State - GlobeNewswire
- 2026-06-18Vireo Growth (VREOD) Stock Price, News & Analysis - Stock Titan
- 2026-06-18Vireo pays $1.55M to take 49% stake in Maryland cannabis dispensaries - Stock Titan
- 2026-06-18Vireo Growth to Acquire C21 Investments via Plan of Arrangement; 0.023052 Share Exchange, Fees Up to $3M - TradingView
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.